A

Atea Pharmaceuticals (AVIR)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Atea Pharmaceuticals (AVIR)

Atea Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections.... Read more

Open
USD2.92
High
USD2.96
Low
USD2.82
52 Week High
USD4.15
Monthly Return
-11.50%
Revenue
--

Avg. Daily Vol.
407.38k
Market Cap.
254M
52 Week Low
2.60
Annual Return
-23.60%

Stock News

Whirlpool says it’s a ‘winner’ under new tariffs, as consumers stay cautious

Whirlpool says it’s a ‘winner’ under new tariffs, as consumers stay cautious

MarketWatch

GE Vernova CEO says current U.S. demand for electricity is the largest since the end of WWII

GE Vernova CEO says current U.S. demand for electricity is the largest since the end of WWII

CNBC

Alaska Airlines warns of slower demand as second-quarter profit outlook falls short

Alaska Airlines warns of slower demand as second-quarter profit outlook falls short

CNBC

Brookline: Q1 Earnings Snapshot

Brookline: Q1 Earnings Snapshot

Yahoo

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.